Africa's leading AI-powered WhatsApp healthcare assistant
Awadoc is revolutionizing healthcare delivery across Africa using artificial intelligence and the widespread accessibility of WhatsApp. Built by renowned health influencer Chinonso Egemba (Aproko Doctor) and Jesse Benedict (MBA, public health/energy leader), Awadoc is the continent’s most accurate AI-powered symptom checker and virtual healthcare triage platform. With a mission to democratize quality care, Awadoc connects millions of patients with medical professionals instantly, bypassing barriers like hospital queues and limited infrastructure.
The company leverages a B2B model offering seamless integration for employers, pharmacies, HMOs, and healthcare organizations, all via WhatsApp. Its intelligent system interprets informal and non-textbook symptom descriptions—crucial in Africa’s dynamic healthcare environments. Awadoc, with headquarters in Lagos and Delaware, is rapidly scaling, now serving over 70,000 users across 20+ African countries.
Awadoc’s leadership team consists of Dr. Chinonso Fidelis Egemba (co-founder), Jesse Benedict (co-founder), and Dr. Julius Kunle Oni (Board of Directors – orthopedic surgeon/Johns Hopkins). Their vision is to empower every African with affordable, instant guidance and holistic wellness through clinical intelligence, advanced AI, and innovative public health strategies.
Julius Kunle Oni, M.D. FAOA
Board of Directors - Orthopedic surgeon at Johns Hopkins University School of Medicine
Jesse Benedict, MBA
Co-founder - Public health/energy leader
Chinonso Fidelis Egemba
Co-founder - Health influencer (Aproko Doctor)/Public health
Chinonso Fidelis Egemba
Co-founder and renowned health influencer known as Aproko Doctor. Building Africa's largest AI Health Infrastructure.
Jesse Benedict, MBA
Co-founder and GMD at Ozone Energy. Building Africa's largest AI healthcare infrastructure.
Julius Kunle Oni, M.D. FAOA
Board of Directors at AwaDoc. Renowned orthopedic surgeon and educator at Johns Hopkins University School of Medicine.